Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest update is out from BCAL Diagnostics Limited ( (AU:BDX) ).
BCAL Diagnostics Limited has announced its Annual General Meeting scheduled for November 28, 2025, at Gadens in Sydney, with an option to attend online. The meeting will address several key resolutions, including the approval of the remuneration report and the re-election of director Jonathan Trollip. Shareholders are encouraged to participate and vote, either in person or by proxy, on these resolutions, which are crucial for the company’s governance and strategic direction.
More about BCAL Diagnostics Limited
BCAL Diagnostics Limited is a company operating in the healthcare industry, focusing on diagnostic solutions. The company is involved in the development and commercialization of innovative diagnostic technologies.
Average Trading Volume: 382,592
Technical Sentiment Signal: Buy
Current Market Cap: A$32.94M
For a thorough assessment of BDX stock, go to TipRanks’ Stock Analysis page.